Financials
Financial year 2025
INJECTIS from Gavere, company number BE0567757232, closed financial year 2025 with a result of € 284,497 after tax. For that financial year INJECTIS recorded a gross margin of € 657,051 and equity of € 955,149. Compared with financial year 2024, the result moved from € 361,767 to € 284,497. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 955,149
▲ 42% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 284,497
▼ 21% vs 2024
Profit after tax over the fiscal year.
€ 617,078
▼ 17% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 893,649.
People and assets in 2025
€ 260,126
▼ 19% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 468,862
▼ 8% vs 2024
€ 186,179 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 129,715
▼ 17% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,428
▲ 5% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 574,833 | € 290,421 | € 648,900 | € 657,051 | ▲ 1% |
| Profit after taxes | € 412,771 | € 141,610 | € 361,767 | € 284,497 | ▼ 21% |
| Equity | € 667,275 | € 808,885 | € 670,652 | € 955,149 | ▲ 42% |
| Total debts | € 299,527 | € 484,659 | € 1,134,132 | € 834,125 | ▼ 26% |
| Cash | € 429,819 | € 183,185 | € 741,400 | € 617,078 | ▼ 17% |
| Retained profit | € 605,775 | € 747,385 | € 609,152 | € 893,649 | ▲ 47% |
| Dividend | € 3,000 | € 0 | € 500,000 | € 0 | ▼ 100% |
| Bank debt | € 222,064 | € 281,923 | € 507,721 | € 468,862 | ▼ 8% |
| Balance sheet total | € 966,802 | € 1,293,544 | € 1,804,783 | € 1,789,274 | ▼ 1% |
Key figures of INJECTIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INJECTIS?
What happened at INJECTIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 284,497 (▼ 21% vs 2024). Source: NBB ↗
- VaViTech bv became a director. NBB
- New establishment in Deinze. KBO
- Start of the company according to the CBE. KBO
In short
From € 412,771 profit in 2022 to € 284,497 profit in 2025.
Paid € 235,386 in corporate taxes since 2022.
Best year ever: 2022, with € 412,771 profit.
Paid out € 503,000 in dividends to the owners in total.
Management
Behind INJECTIS is VaViTech bv.
Directors
According to the 2025 annual accounts
Director · represented by Jeroen Vandenbruwane
since 2026
Establishments
Establishment units
Physical locations of this company
Toekomststraat 15
9890 Gavere
De Tonne 49
9800 Deinze
Active since 12 November 2014
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0567.757.232
- VAT number
- BE 0567.757.232
- Registered office
- Toekomststraat 15, 9890 Gavere
- Names & denominations
- INJECTIS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 12 November 2014
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Sanering en ander afvalbeheer
Overige persoonlijke diensten
Winning, behandeling en distributie van water
Ontwikkeling van residentiële bouwprojecten